Back
Add Comment
Topics
Vote
Results
ocrelizumab
anti-CD20 monoclonal antibody under development for treatment of B cell leukemia and multiple sclerosis
--Agreed Upon Solutions

The discussion does not exist would you like to add the first comment?

anonymous